GLUE · Categories · Form 3

GLUE - SEC Form 3 initial insider statements

Monte Rosa Therapeutics Inc. (GLUE) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for GLUE

• 19d
  SEC Form 3 filed by new insider Bowen Matthew

  3 - Monte Rosa Therapeutics, Inc. (0001826457) (Issuer)
• 499d
  SEC Form 3 filed by new insider Hughes Eric A

  3 - Monte Rosa Therapeutics, Inc. (0001826457) (Issuer)
• 690d
  SEC Form 3 filed by new insider Champoux Jennifer

  3 - Monte Rosa Therapeutics, Inc. (0001826457) (Issuer)
• 690d
  SEC Form 3 filed by new insider Townson Sharon

  3 - Monte Rosa Therapeutics, Inc. (0001826457) (Issuer)
• 982d
  SEC Form 3: New insider Dunn Edmund claimed ownership of 16,761 shares

  3 - Monte Rosa Therapeutics, Inc. (0001826457) (Issuer)
• 1005d
  SEC Form 3 filed by new insider Manning Anthony M.

  3 - Monte Rosa Therapeutics, Inc. (0001826457) (Issuer)
• 1129d
  SEC Form 3 filed by new insider Skvarka Jan

  3 - Monte Rosa Therapeutics, Inc. (0001826457) (Issuer)
• 1516d
  SEC Form 3 filed by new insider Nickson Philip

  3 - Monte Rosa Therapeutics, Inc. (0001826457) (Issuer)
• 1606d
  SEC Form 3 filed by new insider Jones Julian G

  3 - Monte Rosa Therapeutics, Inc. (0001826457) (Issuer)

Other GLUE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends